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MinireviewWhen the Message Goes Awry: Disease-
Producing Mutations that Influence
mRNA Content and Performance
NMD is ubiquitous among eukaryotes and is a predict-
able consequence of PTCs that occur upstream of a
fixed point in the penultimate exon (reviewed in Wilusz
et al., 2001). In that 95% of mammalian genes do not
have introns in the 3 UTR, this spatial constraint effec-
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tively serves to discriminate PTCs from bona fide termi-Baltimore, Maryland 21205
nation codons. However, if the PTC occurs less than 50
bp from the final exon-exon junction (with a few notable
exceptions), then the transcript is not recognized as aMutations that cause disease commonly occur in the
substrate for NMD.coding sequence and directly influence protein struc-
Perhaps the biggest obstacle to achieving a compre-ture and function. However, many diseases result from
hensive understanding of NMD and its implications hasmutations that influence various aspects of mRNA me-
been the inability to fully reconcile selected experimen-tabolism, including processing, export, stability, and
tal observations with basic tenets regarding how andtranslational control.
where the coding potential of transcript can be interpre-
ted. A conservative view would hold that PTCs can onlyThe availability of the human genome sequence repre-
be identified during cytoplasmic translation. Yet theresents an important opportunity to elucidate the genetic
are many observations that implicate nuclear events inbasis of disease. This effort cannot be solely reliant upon
mammalian NMD. Foremost among these is the selec-the observation of mutations that cause an overt or
tive lability of nonsense transcripts that remain associ-intuitive alteration of protein structure or function. Re-
ated with (if not within) the nuclear compartment. Thecent advances in the fields of RNA processing, traffick-
dependence of NMD upon both the history of an introning, turnover, and translational control have revealed
downstream of a PTC and the cytoplasmic translationmany sequence elements that influence these events.
machinery could be reconciled by recognition of a “mark”Mutations at these sites can have overt effects on gene
that is left at the site of a prior splicing event. This functionexpression. Thus, when trying to understand if and how
is plausibly served by cytoplasmic remnants of a proteina mutation contributes to disease, it is necessary to
complex that is deposited near exon-exon junctions in aconsider mechanisms that influence mRNA biogenesis,
splicing-dependent manner (reviewed in Wilkinson andquality control, and metabolic fate in order to achieve
Shyu, 2001). Importantly, both nuclear (hUpf3) and cyto-a fully comprehensive view. This may be particularly true
plasmic (rent2/hUpf2) mammalian orthologs of essentialwhen considering phenotypes that are stochastically
yeast trans-effectors of NMD have been shown to inter-modified, complex, and/or subtle, as such phenotypes
act with components of this so-called exon-exon junc-may be more likely to reflect mutations that simply
tion complex (EJC). Artificial tethering of either proteinnudge gene expression patterns in an unfavorable direc-
downstream of a bona fide termination codon is suffi-tion. Appreciation of the repertoire of mechanisms by
cient to initiate NMD (Lykke-Andersen et al., 2001).which mutations can alter gene function will not only
The current view is that the cytoplasmic remnants offacilitate the correlation of specific diseases with spe-
the EJC are displaced by the translating ribosome as acific genes, but will also aid in the elucidation of disease
message exits from the nuclear pore. A PTC halts thepathogenesis and the development of rational therapeu-
ribosome, allowing more 3 complexes to remain associ-tic strategies.
ated and to serve as a mark of the history of splicingA Whole Lotta Nonsense
during nonsense surveillance. Subsequent recruitment
Up to 30% of mutant alleles that contribute to human
of other mammalian NMD factors (rent2/hUpf2 and ulti-
disease harbor a premature signal for the termination mately rent1/hUpf1) initiates removal of the 5 cap and
of translation, either through nonsense or frameshift mu- exonucleolytic decay while the transcript is still associ-
tations. The most intuitive consequence of such muta- ated with (and therefore cofractionates with) the nu-
tions, which continues to be widely predicted, is the cleus. It has been proposed that a fully assembled
production of protein products truncated at the C-termi- nonsense surveillance complex blocks interactions be-
nal end. On this basis, the functional properties of tween factors bound at the 5 and 3 ends of mRNAs,
N-terminal domains of proteins, including dominant neg- predisposing them to decapping and precluding effi-
ative potential, have been inferred. In reality, the vast cient translation initiation (Mendell et al., 2000).
majority of nonsense alleles give rise to transcripts that When Missense or Nonsense Makes No Sense
are detected and efficiently degraded by the nonsense- This view of NMD is complicated (and perhaps chal-
mediated mRNA decay (NMD) pathway. Nothing can be lenged) by the observation that PTCs can influence ex-
inferred from the position of the PTC regarding function clusively nuclear events such as pre-mRNA abundance,
of N-terminal domains, as little or no protein is made. localization, and processing (reviewed in Wilkinson and
Haploinsufficiency emerges as the most predictable Shyu, 2001). Nonsense mutations in Ig-, Ig-, TCR-,
pathogenetic mechanism for heterozygous nonsense al- and minute virus of mice (MVM) genes have been corre-
leles. lated with an increased abundance of unspliced pre-
mRNAs in the nuclear compartment. The phenomenon
of nonsense-mediated alterations in splicing (NAS) has1Correspondence: hdietz@jhmi.edu
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been most reliably demonstrated by in situ hybridiza- the mutations that initiated NAS had no predictable ef-
fect on ESE consensus sequences, while others uni-tion-based methods that show accumulation of non-
sense pre-mRNAs at the site of transcription (Muhle- formly improved the sites. Finally, the majority of single
base substitutions deep in coding sequence that altermann et al., 2001). Moreover, nonsense mutations in
many mammalian genes have been associated with splicing create PTCs, while only 3 of 64 codons that
occur by chance would have this effect. It should beexon skipping. In at least two examples in the FBN1
and MVM genes, frameshifts in the upstream exon that noted that many of these mutations were detected after
abnormal splicing had been observed, precluding therestored the open reading frame (ORF) to the skipped
exon abolished abnormal splice-site selection, provid- overwhelming contribution of a detection bias.
The Ends Justify the Meansing evidence that exon skipping was frame-dependent.
Importantly, the same manipulation precluded accumu- In addition to mutations inside the ORF that wreak havoc
with processing or stability of mRNA, mutations to eitherlation of PTC-bearing pre-mRNAs deep in the nucleo-
plasm. side can have dramatic effects as well. Critical regula-
tory elements for posttranscriptional control are en-It is important to consider alternative mutational
mechanisms that might contribute to alterations in pre- coded in the 5 and 3 untranslated regions (UTRs). The
5 UTR provides a unique opportunity for translationalmRNA splicing. Occasionally, it has been observed that
missense or even synonymous mutations can influence regulation, since it participates in recruitment and scan-
ning of the 40S ribosomal subunit prior to translationsplicing decisions. This most certainly relates to disrup-
tion of cis-elements that regulate alternative splicing initiation. Hyperferritinemia/cataract syndrome (HHCS),
caused by mutations in the 5 UTR of the L-ferritin gene,(Liu et al., 2001 and references therein). Many human
exons, often at the extremes of length or with relatively manifests loss of translational control. Levels of ferritin
are tightly regulated to maintain iron homeostasis, withweak flanking splice sites, contain or are flanked by
sequences that promote their utilization in a regulated increased production in the presence of high iron and
decreased production when iron is scarce. This strictmanner. Such intronic or exonic splicing enhancers
(ISEs and ESEs, respectively) are recognized by serine/ regulation requires iron-responsive elements (IREs),
hairpin structures in the 5 UTR of the L- and H-ferritinarginine (SR)-rich proteins that promote exon utilization
at developmental stages or in tissues in which they are transcripts which inhibit translation under conditions of
low intracellular iron through interaction with iron re-expressed (Blencowe, 2000; McCarthy and Phillips,
1998 and references therein). Point mutations, deletions, sponsive proteins (IRPs). In HHCS, the IRE of the
L-ferritin transcript is disrupted by mutation, preventingand insertions within or flanking splicing enhancers can
interrupt function, leading to a variety of effects (includ- interaction with IRPs and leading to dysregulated (high)
L-ferritin production (reviewed in Cazzola and Skoda,ing exon skipping, intron retention, or activation of cryp-
tic splice sites) that can contribute to disease. Represen- 2000). While IREs in the 3 UTR of transcripts encoding
other proteins involved in iron metabolism influencetative examples include a synonymous mutation in exon
7 of the SMN1 gene that causes exon skipping and message stability by controlling susceptibility to endo-
nucleolytic cleavage, no naturally occurring mutationsspinal muscular atrophy (Lorson et al., 1999), and a small
deletion in intron 3 of the growth hormone (GH) gene that in regulatory elements have been described (reviewed
in Cazzola and Skoda, 2000).causes skipping of exon 3 and dominant GH deficiency
(McCarthy and Phillips, 1998). This underscores the im- The 40S ribosomal subunit normally initiates scanning
from the 5 cap. There are examples, however, of mam-portance of carefully scrutinizing the context and influ-
ence of any base substitution before eliminating its malian genes that recruit ribosomes directly to internal
sites within the 5 UTR through cis-elements termedpathogenetic candidacy or inferring its mode of in-
fluence. internal ribosome entry sites (IRESs). It was recently
demonstrated that a mutation in the 5 UTR of the con-In a high-profile example of nonsense-mediated exon
skipping in the BRCA1 gene, Krainer and colleagues nexin-32 gene causing Charcot-Marie-Tooth disease
abolished the function of an IRES (Hudder and Werner,reliably demonstrated that the splicing phenotype mani-
fests disruption of an ESE, rather than interruption of 2000). Conversely, a mutation in the c-myc 5 UTR in-
creased the activity of an IRES, promoting excess c-mycthe reading frame (Liu et al., 2001). These authors went
on to show that at least some of the other nonsense production and contributing to multiple myeloma (Chap-
pell et al., 2000). Another sequence feature of the 5mutations associated with abnormal splicing also oc-
curred within sequences that matched, at least to an UTR that can regulate translation initiation as well as
transcript stability is an upstream open reading frameextent, ESE consensus sequences. They also noted that
some exons involved in NAS had been previously dem- (uORF). uORFs consist of initiation and termination co-
dons separated by an ORF of variable length. uORFsonstrated to contain ESEs distant from the PTC, includ-
ing those in the FBN1 and MVM genes. It was concluded can compete for scanning ribosomes, preventing 40S
subunits from reaching the downstream and productivethat these results argued against a nuclear reading-
frame scanning mechanism for NAS. A number of factors ORF. Additionally, since engagement of an uORF often
dictates translation termination upstream of an exon-need to be considered. First, this conclusion does
not reconcile the restorative effects that upstream exon junction, use of an uORF can initiate NMD. Adding
further complexity, certain uORFs in yeast are followedframeshifts had upon splicing. Second, in both exam-
ples, it was shown that all base substitutions that cre- by cis-acting stabilizer elements which prevent the tran-
script from undergoing NMD (Ruiz-Echevarria and Peltz,ated PTCs altered splicing, while all those that main-
tained the ORF did not (Muhlemann et al., 2001; 2000). Thus, it is not easily predictable whether a given
uORF will lead to decreased translation, decreased tran-reviewed in Wilkinson and Shyu, 2001). Third, many of
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Figure 1. Anatomy of a Vulnerable Mes-
senger
Sequence elements that are prone to muta-
tions causing perturbed mRNA content, sta-
bility, and/or translational efficiency are indi-
cated. 5UTR sites include the cap (m7Gppp)
site, hairpins (e.g., iron responsive elements
[IREs] that bind iron responsive proteins
[IRPs]), upstream open reading frames
(uORFs), and internal ribosome entry sites
(IRESs). Coding sequence elements, includ-
ing intronic or exonic splicing enhancers
(ISEs and ESEs, respectively) or premature
termination codons (PTCs), can influence the
performance of pre-mRNAs and mRNAs. 3
UTR sites include AU-rich elements (AREs),
less well-specified cis-elements, regulatory
hairpin structures, or the 3 end processing
signal.
script stability, or both. The thrombopoietin (TPO) gene the HPV-16 genome is associated with loss of the ARE,
message stabilization, increased expression of E6 andcontains multiple uORFs that function to decrease trans-
lation initiation. TPO is a potent humoral stimulator of E7, and malignant transformation (Jeon and Lambert,
1995).platelet formation, and its plasma levels are tightly con-
trolled to prevent excessive thrombosis. Mutations that Fukuyama-type congenital muscular dystrophy
(FCMD) can be caused by another type of 3 UTR alter-disrupt the uORFs of TPO abolish this translational con-
trol and lead to hereditary thrombocythemia (Cazzola ation. An ancient retrotransposal insertion was identified
within the 3 UTR of the FCMD-causative gene and isand Skoda, 2000). Creation of an uORF can also be
pathogenic, as illustrated by a mutation in the gene associated with reduced steady-state levels of the tran-
script (Kobayashi et al., 1998). Although the mechanismencoding cyclin-dependent kinase inhibitor-2A (CKDN2A),
which is associated with familial melanoma. This G-to- is unclear, recent studies in yeast demonstrate that tran-
scripts with extended 3 UTRs can be substrates forT transversion in the 5UTR creates an aberrant initiation
codon, and consequently an uORF, reducing utilization the NMD pathway (Muhlrad and Parker, 1999). Our final
example of a 3 UTR alteration that contributes to dis-of the intended ORF (reviewed in Cazzola and Skoda,
2000). Importantly, for both the TPO and CKDN2A exam- ease pathogenesis occurs in the thrombin gene. A single
nucleotide substitution that is carried by 1%–2% of theples, the effect of creating or destroying the uORFs on
message stability has not been completely examined, population increases the efficiency of 3 end processing,
leading to excess production of mature thrombin mes-raising the possibility that NMD contributes to the patho-
genesis of these disorders. sage and protein, and hence the phenotype of hereditary
thrombophilia (Gehring et al., 2001).The 3 UTR does not have to accommodate scanning
ribosomes and therefore provides greater opportunity Perspective
When it comes to mutational mechanisms that influencefor regulation of message stability through interaction
with trans-acting factors. Perhaps the best understood RNA metabolism, Murphy’s law applies (Figure 1). This
is of more than just academic interest. Appreciation ofexample of this occurs in -thalassemia caused by the
constant spring allele of -globin (cs). This variant con- these mechanisms may promote the development of
therapeutic strategies that can be applied to broadtains a mutation that disrupts the normal termination
codon, allowing translating ribosomes to proceed into classes of human disease. For example, intriguing at-
tempts have been made to treat genetic disorders re-the 3 UTR and displace the so-called  complex of
proteins which normally functions to slow deadenylation sulting from PTCs with long-term and high-dose amino-
glycoside regimens aimed at promoting nonsense(reviewed in Conne et al., 2000). Transcripts harboring
this mutation undergo accelerated decay, reducing codon readthrough (Karpati and Lochmuller, 2001 and
references therein). In theory, this treatment has the-globin production. AU-rich elements (AREs) are short
sequences commonly found in the 3 UTR of mRNAs potential to stabilize nonsense transcripts and promote
the production of truncated peptides that retain someencoding cytokines, oncogenes, and transcription fac-
tors. Regulated trans-factor binding promotes transcript intended function or full-length proteins derived from
readthrough events. In most studies that have been re-lability (reviewed in Wilusz et al., 2001). Mutations in
AREs would be expected to lead to dysregulated (exces- ported, however, expression of functional protein has
been variable and modest, without a definitive demon-sive) protein production. Although few naturally oc-
curring mutations in AREs have been described, one stration of improved mRNA stability. A complete consid-
eration of the underlying mutational mechanism mayrelevant example relates to the pathogenesis of cervical
carcinoma caused by human papillomavirus type 16 offer insight and the potential for productive modifica-
tions. What is the consequence of readthrough of bona(HPV-16) infection. Extrachromosomal HPV-16 genomes,
associated with benign lesions, encode an ARE in the fide termination codons? Do aminoglycosides influence
the earliest events in nonsense surveillance? If not, then3UTR of the early viral region, causing lability of tran-
scripts encoding oncogenes E6 and E7. Integration of message stabilization may not be achieved. Furthermore,
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residual nonsense transcripts may not be trafficked to the
cytoplasm and available to the translation machinery, or
may not be properly assembled into a closed loop confor-
mation, precluding efficient translation inititiation and lim-
iting the opportunity for drug-induced readthrough. In this
view, pharmacologic regimens aimed at impairing non-
sense surveillance, perhaps in combination with the pro-
motion of nonsense suppression, may be more effective.
In turn, the observation that complete disruption of NMD
is incompatible with mammalian embryonic viability may
ultimately limit this approach (Medghalchi et al., 2001).
Clearly, additional basic research will be needed to
guide the development of a rational strategy. Hopefully,
this will not diminish our energy or temper our enthu-
siasm.
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